4.7 Article

MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening

期刊

MOLECULAR THERAPY-NUCLEIC ACIDS
卷 24, 期 -, 页码 188-199

出版社

CELL PRESS
DOI: 10.1016/j.omtn.2021.02.021

关键词

-

资金

  1. Deutsche Forschungsgemeinschaft [Sche 2125/2-1]
  2. University of Leipzig Medical Faculty [934300-022]
  3. University of California Tobacco-Related Disease Research Program [T29IR06360, 26IP-0041]
  4. German Center for Cardiovascular Research (DZHK) e.V. [81X3300104]

向作者/读者索取更多资源

Patients with type 2 diabetes are at increased risk of cardiovascular morbidity and mortality, often linked to accelerated arterial stiffening. This study identifies miR-29b as a key regulator of diabetic aortic remodeling and stiffening, with its downregulation leading to fibrosis and elastin breakdown in the aorta. Targeting miR-29b may offer a potential therapeutic strategy for mitigating cardiovascular risks in type 2 diabetes.
Patients with type 2 diabetes (T2D) are threatened by excessive cardiovascular morbidity and mortality. While accelerated arterial stiffening may represent a critical mechanistic factor driving cardiovascular risk in T2D, specific therapies to contain the underlying diabetic arterial remodeling have been elusive. The present translational study investigates the role of microRNA-29b (miR-29b) as a driver and therapeutic target of diabetic aortic remodeling and stiffening. Using a murine model (db/db mice), as well as human aortic tissue samples, we find that diabetic aortic remodeling and stiffening is associated with medial fibrosis, as well as fragmentation of aortic elastic layers. miR-29b is significantly downregulated in T2D and miR-29b repression is sufficient to induce both aortic medial fibrosis and elastin breakdown through upregulation of its direct target genes COL1A1 and MMP2 thereby increasing aortic stiffness. Moreover, antioxidant treatment restores aortic miR-29b levels and counteracts diabetic aortic remodeling. Concluding, we identify miR-29b as a comprehensive-and therefore powerful-regulator of aortic remodeling and stiffening in T2D that moreover qualifies as a (redox-sensitive) target for therapeutic intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据